Glycaemic control of elderly patients with type 2 diabetes mellitus in Spain (2015) and its relationship with functional capacity and comorbidity. The Escadiane study

• Published in: Revista clínica espanõla (English edition) Vol. 217; no. 9; pp. 495 - 503
• Main Authors: Sangrós-González, F J, Martínez-Candela, J, Avila-Lachica, L, Díez-Espino, J, Millaruelo-Trillo, J M, García-Soidán, J, Carrillo Fernández, L, Ezkurra Loiola, P
• Format: Journal Article
• Language: English; Spanish
• Published: Spain 01.12.2017
• Subjects: Control glucémico; Comorbidity; Ancianos; Diabetes; Elderly; Capacidad funcional; Comorbilidad; Glycaemic control; Functional capacity
• ISSN: 2254-8874
• DOI: 10.1016/j.rce.2017.08.003

To understand the state of glycaemic control of elderly patients with type 2 diabetes mellitus in Spain and its relationship with functional capacity and comorbidity. Cross-sectional, observational, multicentre national study on patients with diabetes mellitus aged 65 years or older. The study analysed demographic and anthropometric variables, cardiovascular risk factors, clinical and laboratory data, associated comorbidity and treatments. We analysed the functional capacity using the Barthel index and the comorbidity with Charlson index. The study included 939 patients with a mean age of 76.4±6.7 years. The mean glycated haemoglobin (HbA1c) level was 7.0%±1.2%, and the mean basal blood glucose level was 137±39.6mg/dL. The HbA1c level showed statistically significant differences depending on the degree of disability. In the patients who were totally, severely, moderately or slightly dependent or who were independent, the mean HbA1c levels were 7.0%, 7.9%, 7.4% and 7.0%, respectively (P<.028). HbA1c levels were 7.3%, 7.1% and 6.9% in the patients with very high, high and medium comorbidity, respectively (P<.001). Mean HbA1c levels in elderly patients with type 2 diabetes analysed in Spain are below those recommended by the main clinical practice guidelines. The levels are higher in patients who have more functional disability and a higher level of comorbidity.